TELA

MKT CAP:$31M

TELA Bio, Inc.

Market Cap

$31M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical - Devices·🇺🇸·NASDAQ

Stock Price

$0.62-$0.52 (-45.61%)

Apr 21, 2026

Company Details

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides ...

CEO

Antony Koblish

IPO Date

Nov 8, 2019

Website

www.telabio.com

Key Metrics TTM

Revenue

$80M

+15.8% YoY

Net Income

-$39M

EPS (Diluted)

-$0.83

Free Cash Flow

-$29M

Revenue / Share

$1.55

Gross Margin

67.7%

Operating Margin

-42.0%

Net Margin

-48.4%

FCF Margin

-35.7%

P/S

0.4x

P/E

—

Earnings Reports

Q1 2026

May 14, 2026

PENDING

FY 2025

Mar 25, 2026

$80M+15.8%EPS -$0.83

Q4 2025

Mar 25, 2026

$21M+18.2%EPS -$0.17

Q3 2025

Nov 14, 2025

$21M+9.1%EPS -$0.19

Q2 2025

Aug 11, 2025

$20M+25.5%EPS -$0.22

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$8M	$5M	-$10M
Q2 22	$10M	$7M	-$10M
Q3 22	$11M	$7M	-$9M
Q4 22	$12M	$8M	-$9M
Q1 23	$12M	$8M	-$11M
Q2 23	$14M	$10M	-$10M
Q3 23	$15M	$10M	-$10M
Q4 23	$17M	$12M	-$12M
Q1 24	$17M	$11M	-$5M
Q2 24	$16M	$11M	-$12M
Q3 24	$19M	$13M	-$9M
Q4 24	$18M	$11M	-$8M
Q1 25	$19M	$13M	-$10M
Q2 25	$20M	$14M	-$9M
Q3 25	$21M	$14M	-$8M
Q4 25	$21M	$14M	-$7M

Valuation

Quarter	P/S	P/E
Q1 22	5.4x	—
Q2 22	3.0x	—
Q3 22	4.3x	—
Q4 22	5.4x	—
Q1 23	5.7x	—
Q2 23	5.0x	—
Q3 23	3.5x	—
Q4 23	3.0x	—
Q1 24	2.1x	—
Q2 24	1.7x	—
Q3 24	0.9x	—
Q4 24	1.0x	—
Q1 25	0.5x	—
Q2 25	1.2x	—
Q3 25	0.9x	—
Q4 25	0.6x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$10M	-$11M
Q2 22	-$12M	-$12M
Q3 22	-$8M	-$8M
Q4 22	-$11M	-$12M
Q1 23	-$12M	-$12M
Q2 23	-$11M	-$11M
Q3 23	-$7M	-$7M
Q4 23	-$11M	-$11M
Q1 24	-$14M	-$15M
Q2 24	-$11M	-$11M
Q3 24	-$9M	-$9M
Q4 24	-$8M	-$8M
Q1 25	-$10M	-$10M
Q2 25	-$8M	-$8M
Q3 25	-$6M	-$6M
Q4 25	-$5M	-$5M

Capital Expenditures

Quarter	CapEx
Q1 22	$336.0K
Q2 22	$200.0K
Q3 22	$290.0K
Q4 22	$1M
Q1 23	$115.0K
Q2 23	$157.0K
Q3 23	$134.0K
Q4 23	$205.0K
Q1 24	$304.0K
Q2 24	$299.0K
Q3 24	$122.0K
Q4 24	$264.0K
Q1 25	$32.0K
Q2 25	$114.0K
Q3 25	$211.0K
Q4 25	$91.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+40.1%	+37.5%
Q2 22	+37.7%	+38.8%
Q3 22	+45.8%	+38.8%
Q4 22	+38.8%	+31.4%
Q1 23	+44.7%	+28.1%
Q2 23	+39.3%	+20.4%
Q3 23	+34.9%	+22.2%
Q4 23	+46.3%	+39.0%
Q1 24	+39.4%	-7.5%
Q2 24	+11.0%	+11.3%
Q3 24	+25.9%	+12.2%
Q4 24	+3.8%	-11.2%
Q1 25	+11.5%	+35.3%
Q2 25	+25.5%	+5.8%
Q3 25	+9.1%	-0.3%
Q4 25	+18.2%	+5.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$901.0K	10.9%
Q2 22	$0	0.0%
Q3 22	$1M	9.2%
Q4 22	$1M	8.9%
Q1 23	$1M	9.5%
Q2 23	$1M	8.9%
Q3 23	$1M	9.1%
Q4 23	$1M	7.3%
Q1 24	$1M	6.6%
Q2 24	$1M	6.8%
Q3 24	$1M	5.7%
Q4 24	$1M	6.2%
Q1 25	$1M	5.6%
Q2 25	$985.0K	4.9%
Q3 25	$0	0.0%
Q4 25	$812.0K	3.9%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 22	$2M	$3M	$9M
Q2 22	$2M	$4M	$11M
Q3 22	$2M	$4M	$11M
Q4 22	$3M	$3M	$12M
Q1 23	$2M	$4M	$13M
Q2 23	$3M	$3M	$15M
Q3 23	$2M	$4M	$14M
Q4 23	$3M	$4M	$17M
Q1 24	$2M	$4M	$18M
Q2 24	$2M	$4M	$17M
Q3 24	$2M	$4M	$16M
Q4 24	$2M	$4M	$14M
Q1 25	$3M	$4M	$17M
Q2 25	$2M	$4M	$17M
Q3 25	$2M	$4M	$15M
Q4 25	$2M	$4M	$14M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$33M	$0	$33M
Q2 22	$28M	$0	$28M
Q3 22	$54M	$0	$54M
Q4 22	$42M	$0	$42M
Q1 23	$30M	$0	$30M
Q2 23	$65M	$0	$65M
Q3 23	$58M	$0	$58M
Q4 23	$47M	$0	$47M
Q1 24	$37M	$0	$37M
Q2 24	$26M	$0	$26M
Q3 24	$17M	$0	$17M
Q4 24	$53M	$0	$53M
Q1 25	$43M	$0	$43M
Q2 25	$35M	$0	$35M
Q3 25	$30M	$0	$30M
Q4 25	$51M	$0	$51M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	15M	+0.2%	+0.7%
Q2 22	15M	+0.1%	+0.7%
Q3 22	17M	+15.1%	+15.7%
Q4 22	19M	+14.3%	+32.1%
Q1 23	19M	+0.1%	+32.0%
Q2 23	23M	+21.1%	+59.6%
Q3 23	24M	+5.4%	+46.1%
Q4 23	24M	+0.0%	+27.8%
Q1 24	25M	+0.4%	+28.1%
Q2 24	25M	+0.3%	+6.1%
Q3 24	25M	+0.2%	+0.9%
Q4 24	40M	+62.2%	+63.6%
Q1 25	45M	+13.0%	+84.2%
Q2 25	45M	+0.2%	+83.9%
Q3 25	45M	+0.1%	+83.9%
Q4 25	52M	+13.8%	+29.0%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$98.0K	84
Q2 22	$123.9K	84
Q3 22	$132.8K	84
Q4 22	$94.5K	123
Q1 23	$96.8K	123
Q2 23	$117.8K	123
Q3 23	$122.4K	123
Q4 23	$102.4K	166
Q1 24	$100.0K	166
Q2 24	$96.9K	166
Q3 24	$114.2K	166
Q4 24	$132.7K	133
Q1 25	$139.2K	133
Q2 25	$151.9K	133
Q3 25	$155.6K	133
Q4 25	$139.1K	150

Revenue / Employee